Literature DB >> 30191832

Time to act on injectable-free regimens for children with multidrug-resistant tuberculosis.

James A Seddon1, H Simon Schaaf2, Ben J Marais3, Lindsay McKenna4, Anthony J Garcia-Prats2, Anneke C Hesseling2, Jennifer Hughes2, Pauline Howell5, Anne Detjen6, Farhana Amanullah7, Urvashi Singh8, Iqbal Master9, Carlos M Perez-Velez10, Nirupa Misra9, Mercedes C Becerra11, Jennifer J Furin11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30191832     DOI： 10.1016/S2213-2600(18)30329-1

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  6 in total

1.  Diagnosis and Management of Multidrug-Resistant Tuberculosis in Children: A Practical Approach.

Authors:  H Simon Schaaf
Journal:  Indian J Pediatr       Date:  2019-01-17       Impact factor: 1.967

2.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

Review 3.  Newer Drugs for Tuberculosis Prevention and Treatment in Children.

Authors:  Ben J Marais
Journal:  Indian J Pediatr       Date:  2019-02-01       Impact factor: 1.967

4.  Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.

Authors:  Shubhangi Dhakulkar; Mrinalini Das; Narendra Sutar; Vikas Oswal; Daksha Shah; Shilpa Ravi; Dipa Vengurlekar; Vijay Chavan; Lorraine Rebello; Augusto C Meneguim; Aparna Iyer; Homa Mansoor; Stobdan Kalon; Shrikala Acharya; Gabriella Ferlazzo; Petros Isaakidis; Harshad P Thakur
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

5.  XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems.

Authors:  Monika Kozińska; Krystyna Bogucka; Krzysztof Kędziora; Jolanta Szpak-Szpakowska; Wiesława Pędzierska-Olizarowicz; Andrzej Pustkowski; Ewa Augustynowicz-Kopeć
Journal:  Diagnostics (Basel)       Date:  2022-02-08

6.  Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis.

Authors:  Rovina Ruslami; Fajri Gafar; Vycke Yunivita; Ida Parwati; Ahmad R Ganiem; Rob E Aarnoutse; Bob Wilffert; Jan-Willem C Alffenaar; Heda M Nataprawira
Journal:  Arch Dis Child       Date:  2021-06-28       Impact factor: 3.791
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.